STOCK TITAN

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
SI-BONE, Inc. (SIBN) will report financial results for Q4 and full year 2023 on February 26, 2024. The company specializes in medical devices for musculoskeletal disorders. A conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET, with the webcast available on the company's website.
Positive
  • None.
Negative
  • None.

SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Monday, February 26, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/qe3y86y3. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since pioneering minimally invasive surgery of the SI joint in 2009, SI-BONE has supported over 3,600 surgeons in performing a total of more than 95,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 125 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.

For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.

iFuse Bedrock Granite, iFuse-TORQ and SI-BONE are registered trademarks of SI-BONE, Inc. ©2024 SI-BONE, Inc. All Rights Reserved.

Investor Contact: Saqib Iqbal investors@si-bone.com


FAQ

When will SI-BONE, Inc. (SIBN) report financial results for Q4 and full year 2023?

SI-BONE, Inc. (SIBN) will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Monday, February 26, 2024.

What does SI-BONE, Inc. (SIBN) specialize in?

SI-BONE, Inc. (SIBN) is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy.

When is the conference call for SI-BONE, Inc. (SIBN) financial results?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day as the financial results report.

Where can investors listen to the conference call for SI-BONE, Inc. (SIBN) financial results?

Investors can listen to the conference call by registering at the provided link and access the live audio webcast on the 'Investors' section of the company’s website.

SI-BONE, Inc.

NASDAQ:SIBN

SIBN Rankings

SIBN Latest News

SIBN Stock Data

546.04M
37.66M
2.32%
104.51%
3.03%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SANTA CLARA